DR. Mark Alan Mandelkern, M.D.'s direct phone number is available to Dmand AI subscribers. To access their direct number, start a free trial.

DR. Mark Alan Mandelkern, M.D. is a Nuclear Medicine Physician physician currently practicing at West Los Angeles VA Medical Center in Los Angeles, California. They hold admitting privileges at 1 hospital(s), including VA GREATER LOS ANGELES HEALTHCARE SYSTEM. To see all the affiliations of DR. Mark Alan Mandelkern, M.D., start a free trial.

DR. Mark Alan Mandelkern, M.D. is a board-certified Nuclear Medicine Physician physician. They practice at West Los Angeles VA Medical Center in Los Angeles, California.

DR. Mark Alan Mandelkern, M.D. performs procedures across 0 clinical categories. Their most commonly billed procedures based on Medicare claims data include , , and . Full procedure and CPT code data is available to Dmand AI subscribers, start a free trial.

DR. Mark Alan Mandelkern, M.D.'s National Provider Identifier (NPI) is 1306946926. This is a public identifier issued by CMS and can be verified at the NPPES NPI Registry. Their primary taxonomy code is 207U00000X, corresponding to Nuclear Medicine Physician.

The EHR and practice technology used by DR. Mark Alan Mandelkern, M.D. at West Los Angeles VA Medical Center is available to Dmand AI subscribers. Sign up for a free trial to unlock the full technology stack.

DR. Mark Alan Mandelkern, M.D. accepts 0 insurance plans. A full list of accepted payers is available in the profile above.

DR. Mark Alan Mandelkern, M.D. holds hospital privileges at 1 institution(s). Their primary affiliation is VA GREATER LOS ANGELES HEALTHCARE SYSTEM in Los Angeles, California.

DR. Mark Alan Mandelkern, M.D. is board certified by American Board of Nuclear Medicine in Nuclear Medicine. They have maintained this certification since .

DR. Mark Alan Mandelkern, M.D. received their medical degree from University of Miami, Miller School of Medicine in 1975. They completed their Nuclear Medicine residency at UCLA David Geffen School of Medicine/UCLA Medical Center.

Based on CMS Medicare Part B claims data, DR. Mark Alan Mandelkern, M.D. served approximately 0 Medicare beneficiaries in 2023. Total patient volume including non-Medicare patients is available to Dmand AI subscribers.

DR. Mark Alan Mandelkern, M.D.'s group practice affiliation details are available to Dmand AI subscribers.

DR. Mark Alan Mandelkern, M.D. has 149 indexed publications on record and no active clinical trial listings were found at time of last verification. Their research activity is available to Dmand AI subscribers. Sign up for a free trial to unlock their full research activity.